<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:NCBITaxon="http://purl.obolibrary.org/obo/NCBITaxon#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                               NIH Public Access <br />                                Author Manuscript <br />                                Cell. Author manuscript; available PMC 2013 October 25. <br />                            Published final edited form as: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Cell. 2013 April 25; 153(3): 614&#8211;627. doi:10.1016/j.cell.2013.03.040. <br />  <br />  <br />  <br />                            Proteasome regulation ADP-ribosylation <br />                            Park F. Cho-Park Hermann Steller* <br />                            Strang Laboratory Apoptosis <span id='am-9' about='obo:NCBITaxon_6754' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_72041 obo:NCBITaxon_33154 obo:NCBITaxon_6681 obo:NCBITaxon_6682 obo:NCBITaxon_6683 obo:NCBITaxon_29964 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_33208 obo:NCBITaxon_116706 obo:NCBITaxon_116704 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_6656 obo:NCBITaxon_6692 obo:NCBITaxon_1206794 obo:NCBITaxon_6657 obo:NCBITaxon_6753 obo:NCBITaxon_88770 obo:NCBITaxon_6752'><span id='am-10' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-11'  ></span><span id='am-12' property="rdfs:label" content="Cancer" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Cancer</span> Biology, Howard Hughes Medical Institute, The <br />                            Rockefeller University, 1230 York Avenue, New York, NY 10021, USA <br />  <br />                            Summary <br />                                  Protein degradation ubiquitin-proteasome central cell homeostasis survival. <br />                                  Defects process associated diseases cancer neurodegenerative <br />                                  disorders. The 26S proteasome large protease complex degrades ubiquitinated proteins. <br />                                  Here ADP-ribosylation promotes 26S proteasome activity Drosophila and <br />                                  human cells. We identify ADP-ribosyl transferase Tankyrase (TNKS) 19S assembly <br />                                  chaperones dp27 dS5b direct binding partners proteasome regulator PI31. TNKS- <br />                                  mediated ADP-ribosylation PI31 drastically reduces affinity 20S proteasome &#945;-subunits <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  relieve 20S repression PI31. Additionally, PI31 modification increases binding and <br />                                  sequestration dp27 dS5b 19S regulatory particles, promoting 26S assembly. Inhibition <br />                                  TNKS RNAi small-molecule inhibitor, XAV939, blocks process reduce <br />                                  26S assembly. These results unravel mechanism proteasome regulation targeted <br />                                  existing small-molecule inhibitors. <br />  <br />  <br />                            Introduction <br />                                              Selective protein degradation plays central role removal misfolded, potentially <br />                                              toxic proteins, control cell cycle progression, regulation gene expression, and <br />                                              changes cell size morphology (Baumeister et al., 1998; Demartino Gillette, 2007; <br />                                              Finley, 2009; Glickman Ciechanover, 2002; Hershko, 2005; Hershko Ciechanover, <br />                                              1998; Murata et al., 2009; Tanaka et al., 2012). Moreover, abnormal protein degradation is <br />                                              associated wide range human diseases, cancer, muscle wasting diseases <br />                                              neurodegenerative disorders (Glickman Ciechanover, 2002; Goldberg, 2007; <br />                                              Hershko Ciechanover, 1998). The selective degradation intracellular proteins is <br />                                              carried ubiquitin-proteasome-system (UPS) (Finley, 2009; Glickman and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              Ciechanover, 2002; Hershko Ciechanover, 1998; Varshavsky, 2012). Proteins tagged <br />                                              poly-ubiquitin chains hydrolyzed small peptides 26S proteasome an <br />                                              energy-dependent manner (Baumeister et al., 1998; Besche et al., 2009b; Demartino and <br />                                              Gillette, 2007; Finley, 2009; Tanaka et al., 2012; Tomko Hochstrasser, 2011). <br />  <br />                                              The 26S proteasome large protease complex composed catalytic 20S subunit (also <br />                                              known 20S core particle) 19S regulatory particle caps ends the <br />                                              20S proteasome (Baumeister et al., 1998; Besche et al., 2009b; Demartino Gillette, <br />                                              2007; Finley, 2009; Lander et al., 2012; Lasker et al., 2012; Murata et al., 2009; Tanaka et <br />                                              al., 2012; Tomko Hochstrasser, 2011). The assembly activity 26S proteasome <br />  <br />  <br />                            &#169; 2013 Elsevier Inc. All rights reserved <br />                            * <br />                             Corresponding: author: steller@rockefeller.edu. <br />                            Publisher&apos;s Disclaimer: <span id='am-17' about='obo:NCBITaxon_169495' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_169440 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_33154 obo:NCBITaxon_43738 obo:NCBITaxon_480117 obo:NCBITaxon_33317 obo:NCBITaxon_169449 obo:NCBITaxon_480118 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_43750 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_169455 obo:NCBITaxon_50557 obo:NCBITaxon_43741'><span id='am-18' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-20'  ></span><span id='am-21' property="rdfs:label" content="This" datatype="xsd:string"></span>This</span> PDF file unedited manuscript accepted publication. As service our <br />                            customers providing early version manuscript. The manuscript undergo copyediting, typesetting, review of <br />                            resulting proof published final citable form. Please note production process errors be <br />                            discovered affect content, legal disclaimers apply journal pertain. <br />                             Cho-Park Steller                                                                                           Page 2 <br />  <br />  <br />                                                   tightly regulated large number loosely associated proteins function as <br />                                                   regulators cofactors (Besche et al., 2009b; Finley, 2009; Tanaka et al., 2012; Tomko and <br />                                                   Hochstrasser, 2011). One factor PI31, evolutionarily conserved regulator of <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   proteasome activity (Bader et al., 2011; Chu-Ping et al., 1992; McCutchen-Maloney et al., <br />                                                   2000; Zaiss et al., 1999). PI31 initially identified based ability inhibit 20S <br />                                                   proteasome activity vitro (Chu-Ping et al., 1992; McCutchen-Maloney et al., 2000; Zaiss <br />                                                   et al., 1999). However, PI31 activate 26S proteasome vitro, mutational <br />                                                   inactivation corresponding gene Drosophila causes lethality, reduced proteasome <br />                                                   activity defects protein degradation vivo (Bader et al., 2011). Therefore, PI31 <br />                                                   serves crucial physiological function activator 26S proteasome activity. The C- <br />                                                   terminus PI31 contains functionally important HbYX (Hydrophobic residue-Tyrosine- <br />                                                   amino acid) motif, commonly modulators proteasome activity, such <br />                                                   Rpt base subunits 19S regulatory particle (Gillette et al., 2008; Rabl et al., 2008; <br />                                                   Smith et al., 2007). This suggests PI31 bind 20S particle HbYX-motif, <br />                                                   cause inhibition hindering substrate access enzymatic core (Bader et <br />                                                   al., 2011; McCutchen-Maloney et al., 2000). However, precise molecular mechanism by <br />                                                   PI31 modulates proteasome activity remains unknown. Previous work indicated <br />                                                   PI31 function regulated vivo increase 26S proteasome activity conditions <br />                                                   maximal proteolytic activity required, example removal cellular <br />                                                   proteins terminal differentiation sperm (Bader et al., 2011). To gain further <br />                                                   insight regulation PI31 activity looked novel binding partners this <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   protein identified ADP-ribosyl transferase tankyrase (TNKS) direct interactor <br />                                                   modulates PI31 activity. TNKS-mediated ADP-ribosylation PI31 necessary the <br />                                                   ability protein stimulate 26S proteasome function, inhibition TNKS reduces <br />                                                   26S proteasome activity Drosophila mammalian cells. TNKS-mediated ADP- <br />                                                   ribosylation PI31 drastically reduces affinity protein binding 20S <br />                                                   proteasome &#945;-subunits relieves 20S repression PI31. We identified the <br />                                                   19S assembly chaperones dp27 dS5b binding partners PI31. In case, ADP- <br />                                                   ribosylation PI31 causes increased binding dp27 dS5b, sequestration these <br />                                                   assembly chaperones 19S regulatory particles, promotes 26S assembly. These <br />                                                   results reveal novel mechanism proteasome regulation define TNKS-inhibitors a <br />                                                   new <span id='am-14' about='obo:NCBITaxon_class' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-15' property="rdfs:label" content="class" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>class</span> proteasome modulators utility clinic. <br />  <br />                               Results <br />                               dTNKS interacts DmPI31 <br />                                                   To gain insight mechanism PI31-mediated proteasome regulation, looked for <br />                                                   binding partners protein. For purpose, screened Drosophila embryo cDNA <br />                                                   library Far-Western analysis using P32-labeled HMK-tagged Drosophila PI31 (DmPI31) <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   probe. This led identification Drosophila tankyrase (dTNKS, CG4719) a <br />                                                   potential interacting protein (<span id='am-43' about='obo:NCBITaxon_1369087' typeof='obo:NCBITaxon_37567 owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_37570 obo:NCBITaxon_41191 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_41196 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_95182 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7100 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-44' property="rdfs:label" content="Data" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-47'  ></span>data</span> shown). dTNKS protein 44% homologous human <br />                                                   tankyrase 1 2 (hTNKS1/2; Figure S1A). Next, used co-IP experiments investigate <br />                                                   endogenous interactions DmPI31 dTNKS (Figure 1B). Extracts wild-type <br />                                                   (WT) embryos immunoprecipitated anti-DmPI31 blots probed an <br />                                                   antibody raised dTNKS (Figures 1A S1B). These experiments dTNKS <br />                                                   DmPI31 form complex vivo (Figure 1B). We co-expressed FLAG-tagged <br />                                                   dTNKS HA-tagged DmPI31 human 293 cells establish cell culture for <br />                                                   subsequent interaction studies (Figure 1C). Again, co-IP experiments extracts from <br />                                                   cells showed presence DmPI31:dTNKS complex (Figure 1C). <br />  <br />                                                   TNKS belongs poly(ADP-ribose) polymerase (PARP) super-<span id='am-1' about='obo:NCBITaxon_family' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-2' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="family" datatype="xsd:string"></span>family</span> (D&#8217;Amours et al., <br />                                                   1999; Hsiao Smith, 2008; Smith et al., 1998). TNKSs play diverse roles telomere <br />                                                   maintenance, centrosome maturation, Wnt signaling, embryonic development the <br />  <br />                                                          Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                           Page 3 <br />  <br />  <br />                                                   pathogenesis Cherubism (Guettler et al., 2011; Hsiao Smith, 2008; Huang et al., <br />                                                   2009; Levaot et al., 2011). TNKSs recruit modify target proteins ADP-ribosylation <br />                                                   using Ankyrin (ANK) PARP domains (Figure S1A) (Guettler et al., 2011; Hsiao <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Smith, 2008; Huang et al., 2009; Levaot et al., 2011; Morrone et al., 2012; Smith et al., <br />                                                   1998). Unlike mammals, isoforms TNKS partially redundant function <br />                                                   present, Drosophila genome contains TNKS (Chiang et al., 2008; Chiang et <br />                                                   al., 2006; Hsiao et al., 2006; Hsiao Smith, 2008; Yeh et al., 2009). In <span id='am-25' about='obo:NCBITaxon_order' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-26' property="rdfs:label" content="order" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>order</span> identify <br />                                                   region dTNKS responsible interaction DmPI31, generated <br />                                                   truncations dTNKS lack ANK SAM-PARP domains tested for <br />                                                   binding DmPI31 (Figures 1D 1E). Whereas SAM-PARP domains were <br />                                                   dispensable DmPI31-binding, deletion ANK domain dTNKS &#916;ANK mutant <br />                                                   prevented formation DmPI31:dTNKS complex (Figure 1E). This suggests that <br />                                                   dTNKS binds DmPI31 ANK-domain. <br />  <br />                                                   A hallmark TNKS-binding partners presence canonical TNKS-binding motif <br />                                                   (RxxGxGxE/D) (Guettler et al., 2011; Hsiao Smith, 2008; Levaot et al., 2011). DmPI31 <br />                                                   contains good fit consensus motif N-terminus (Figure 1F). To investigate the <br />                                                   functional importance motif, mutated sequence altering amino acids <br />                                                   (RG49/54AA) tested binding dTNKS. The mutant protein longer able form <br />                                                   complex dTNKS, indicating motif required interaction dTNKS <br />                                                   (Figure 1G, lane 2). To characterize DmPI31-dTNKS interaction, generated <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   DmPI31 mutants C-terminal residues, including HbYX motif, either <br />                                                   mutated deleted (L210A, D211K, F241A P243A &#916;HbYX - Figure 1G; lanes 3&#8211; <br />                                                   7). Whereas DmPI31D211K DmPI31P243A mutants retained ability bind dTNKS, <br />                                                   DmPI31L210A DmPI31F241A unable form complex dTNKS (Figure 1G). <br />                                                   Furthermore, deletion HbYX motif DmPI31 abrogated interaction between <br />                                                   DmPI31 dTNKS (Figure 1G, lane 7). This suggests dTNKS uses ANK-domain <br />                                                   bind DmPI31, N-terminal TNKS-binding motif C-terminal <br />                                                   HbYX domain DmPI31 required interaction dTNKS. <br />  <br />                               dTNKS ADP-ribosylates DmPI31 <br />                                                   TNKSs modulate activity target proteins ADP-ribosylation (Hsiao Smith, <br />                                                   2008; Huang et al., 2009; Smith et al., 1998). Therefore, investigated DmPI31 is <br />                                                   substrate dTNKS-mediated ADP-ribosylation. First, used Western blot analysis <br />                                                   monoclonal antibody recognizing poly ADP-ribosylation (PAR) that <br />                                                   DmPI31 ADP-ribosylated vivo (Figure 2A, lane 3). Next, performed vitro <br />                                                   ADP-ribosylation assay incubating Biotin-labeled NAD+ His-DmPI31 with <br />                                                   FLAG-dTNKSWT His-dTNKS &#916;PARP recombinant proteins (Figure 2B). These <br />                                                   experiments demonstrated dTNKS directly ADP-ribosylate DmPI31 vitro, and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   activity requires PARP domain. <br />  <br />                                                   We investigated significance TNKS-mediated ADP-ribosylation PI31 function and <br />                                                   proteasome regulation, Drosophila subsequently mammalian cells. For this <br />                                                   purpose, took advantage small molecule inhibitor hTNKS1/2, XAV939 (Huang et <br />                                                   al., 2009). XAV939 discovered screen small molecules affecting Wnt/&#946;- <br />                                                   catenin signaling pathway (Huang et al., 2009). XAV939 highly specific inhibitor of <br />                                                   hTNKS1/2 (Kd = 0.09 &#956;M) anti-cancer effects APC-deficient colorectal <br />                                                   cancer cells (Huang et al., 2009). We tested ability XAV939 inhibit dTNKS and <br />                                                   able inhibit auto-ADP-ribosylation activity dTNKS, PARP <br />                                                   (Figures 2C S2A) (Gibson Kraus, 2012; Smith et al., 1998). Therefore, XAV939 is <br />                                                   effective specific TNKS-inhibitor Drosophila. <br />  <br />  <br />  <br />  <br />                                                          Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                            Page 4 <br />  <br />  <br />                               TNKS regulates proteasome activity ADP-ribosylation <br />                                                   Because DmPI31 required optimal proteasome activity vivo, dTNKS <br />                                                   post-translationally modulate DmPI31, explored possibility inhibition of <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   TNKS affects proteasome function. First, examined effect TNKS-inhibitor <br />                                                   XAV939 26S proteasome activity Drosophila. Extracts 0&#8211;2h WT embryo were <br />                                                   treated different compounds assayed changes proteasome activity (Figure <br />                                                   2E). Treatment XAV939 significantly reduced 26S proteasome activity (Figure 2E). <br />                                                   Although treatment XAV939 did cause complete inhibition proteasome activity <br />                                                   observed MG312, effect similar inactivation DmPI31 (Bader et al., <br />                                                   2011). These results consistent requirement dTNKS DmPI31-mediated <br />                                                   proteasome activation. Next asked XAV939 inhibit proteasome <br />                                                   activity mammalian cells. For purpose, treated 293 cell extracts XAV939 and <br />                                                   measured 26S proteasome activity (Figure 2F). Again, exposure this <br />                                                   compound decreased proteasome activity. Similar results obtained IWR-1, <br />                                                   TNKS inhibitor structurally unrelated XAV939 (Figure S2B) (Chen et al., <br />                                                   2009; Narwal et al., 2012). This supports conclusion observed decrease in <br />                                                   proteasome activity caused TNKS inhibition, unrelated off-target effect of <br />                                                   XAV939. To corroborate <span id='am-4' about='obo:NCBITaxon_76236' typeof='owl:Thing obo:NCBITaxon_37567 obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_30248 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_33415 obo:NCBITaxon_33317 obo:NCBITaxon_41191 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_37572 obo:NCBITaxon_304572 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_41196 obo:NCBITaxon_197563 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_127218 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-5' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-6'  ></span><span id='am-7' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-8' property="rdfs:label" content="Idea" datatype="xsd:string"></span>idea</span>, used RNAi target TNKS both <br />                                                   Drosophila mammalian cells. First, expressed RNAi dTNKS the <br />                                                   Drosophila retina background compromised proteasome activity (Figure 3). <br />                                                   Specifically, expression temperature sensitive dominant negative mutant 20S <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   proteasome &#946;2 &#946;6 subunits causes rough, reduced eye (Belote Fortier, 2002). <br />                                                   Expression RNAi dTNKS enhanced phenotype, similarly was <br />                                                   previously observed reduction DmPI31 function (Figures 3C&#8211;E) (Bader et al., 2011). <br />                                                   Therefore, down-regulation dTNKS reduces proteasome activity vivo. Finally, used <br />                                                   siRNA knock-down hTNKS1 hTNKS2 human 293 cells (Figure 2D). Again, a <br />                                                   significant reduction 26S proteasome activities observed (Figure 2G). Taken <br />                                                   together, results TNKS stimulates proteasome activity ADP-ribosylation <br />                                                   PI31. <br />  <br />                               ADP-ribosylation blocks DmPI31 inhibition 20S proteasomes <br />                                                   Best known role DNA damage, ADP-ribosylation transient post-translational <br />                                                   modification drastically alter physical properties target proteins (Chambers et <br />                                                   al., 2012; Gagne et al., 2006; Gibson Kraus, 2012; Wang et al., 2009). In order to <br />                                                   understand biochemical consequences TNKS-mediated ADP-ribosylation PI31, we <br />                                                   investigated modification affects binding properties protein. In <br />                                                   mammalian cells, PI31 bind 20S proteasomes (McCutchen-Maloney et al., 2000; <br />                                                   Zaiss et al., 1999). Likewise, DmPI31 bind 20S proteasomes in <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Drosophila (Figure 4A). In particular, DmPI31 bound selectively &#945;-subunits: &#945;1, <br />                                                   &#945;3, &#945;4 &#945;6, &#945;2 &#945;5 (Figure 4A). Next, used co-immunoprecipitation <br />                                                   experiments evaluate role ADP-ribosylation DmPI31: &#945; 4-complex. <br />                                                   Whereas unmodified His-PI31 strongly interacted &#945;4, binding ADP-ribosylated <br />                                                   version significantly diminished (Figure 4B). Consistent observed change in <br />                                                   DmPI31 affinity &#945;-subunits, ADP-ribosylation interfered ability <br />                                                   PI31 inhibit 20S proteasome particles (Figure 4C). These results demonstrate that <br />                                                   ADP-ribosylation blocks binding DmPI31 20S subunits relieves repression their <br />                                                   proteolytic activity protein. <br />  <br />                               dTNKS DmPI31 actively participates proteasome assembly <br />                                                   Since TNKS-mediated ADP-ribosylation PI31 affects 20S 26S proteasome <br />                                                   activities, investigated possible role TNKS PI31 26S proteasome assembly. <br />                                                   For this, performed Superose 6 gel filtration (FPLC) assays native gel analyses to <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                             Page 5 <br />  <br />  <br />                                                   study effect TNKS-inhibitor XAV939 proteasome assembly. Drosophila embryos <br />                                                   ideal study effects 26S assembly ~65% proteasomes exist as <br />                                                   20S particles (Nickell et al., 2007). XAV939 treatment Drosophila embryo extracts led to <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   significant shift Rpt bands lighter fractions compared controls, it <br />                                                   prevented formation 26S proteasomes analyzed native gels (Figures 5A, 5B, <br />                                                   S3A S3B). This indicates TNKS activity promotes 26S proteasome assembly. <br />  <br />                                                   Next examined effect PI31 26S proteasome assembly. Again, used gel <br />                                                   filtration assays analyze embryo extracts supplemented high concentrations His- <br />                                                   DmPI31 recombinant protein (Figure 5C). Again, addition His-DmPI31 caused a <br />                                                   significant change proteasome architectural landscape redistributing Rpt3 bands <br />                                                   (Figure 5C). We observed increase Rpt3 monomers (Figure 5C; panel - <br />                                                   fractions 20&#8211;23). These effects seen WT DmPI31, mutant lacking the <br />                                                   HbYX motif (Figure 5C). The increase Rpt3 monomers explained ability of <br />                                                   PI31 bind 19S assembly chaperones (see below) known stabilize assembly <br />                                                   19S regulatory particle 26S proteasome (Funakoshi et al., 2009; Kaneko et al., <br />                                                   2009; Le Tallec et al., 2009; Park et al., 2009; Roelofs et al., 2009; Saeki et al., 2009). <br />                                                   Collectively, results TNKS activity PI31 modulate 26S <br />                                                   proteasome assembly, suggest role PI31 promoting 19S stability. <br />  <br />                               19S assembly chaperones interact DmPI31 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   To better understand role DmPI31 proteasome assembly, looked additional <br />                                                   DmPI31 binding partners. In screen revealed dTNKS DmPI31 interactor, <br />                                                   discovered proteasome-associated proteins, Drosophila p27 (dp27; CG9588) <br />                                                   Drosophila S5b (dS5b; CG12096). p27 S5b play known role 19S assembly <br />                                                   chaperones and, Rpn14 Nas6, bind 19S Rpt subunits foster orderly <br />                                                   proteasome assembly (Funakoshi et al., 2009; Kaneko et al., 2009; Le Tallec et al., 2009; <br />                                                   Park et al., 2009; Roelofs et al., 2009; Saeki et al., 2009). As yeast human, the <br />                                                   Drosophila homologs 19S assembly chaperones (dp27: 41% dS5b: 23.3% <br />                                                   homologous; Figures 6B S5A) essential genes required organismal viability <br />                                                   (Figures 3F&#8211;L, S4A S4B). IP experiments anti-DmPI31 using Drosophila embryo <br />                                                   extracts followed Western analysis using anti-dp27 reveal DmPI31 binds dp27 in <br />                                                   vivo (Figures 6A S4C). To identify DmPI31 residues involved dp27 dS5b <br />                                                   binding, used point mutants previously employed map DmPI31:dTNKS <br />                                                   interaction (Figure 1G). While mutants defective TNKS-binding (RG49/54AA) failed to <br />                                                   destabilize DmPI31:assembly chaperone complex, mutating conserved C-terminus of <br />                                                   DmPI31 (L210, F241 HbYX motif) disrupted interactions (Figures 6C S5B). <br />                                                   These results C-terminal HbYX motif required formation a <br />                                                   complex DmPI31 assembly chaperones dp27 dS5b. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Despite structural differences, 19S assembly chaperones use common mechanism to <br />                                                   bind 19S Rpt subunits (Barrault et al., 2012; Funakoshi et al., 2009; Lee et al., 2011; Park <br />                                                   et al., 2009; Roelofs et al., 2009; Saeki et al., 2009; Takagi et al., 2012). Since dp27 and <br />                                                   dS5b interact DmPI31 C-terminus, performed protein sequence alignments <br />                                                   dp27, dS5b dRpn14. This identified putative DmPI31-binding motifs (I&#8211;III; <br />                                                   Figure 6D). In order test functional relevance motifs, mutated sites <br />                                                   examined consequences DmPI31 interaction (Figures 6E S5C). Point <br />                                                   mutations replaced key residues motifs I III dp27 dS5b (dp27: E9A and <br />                                                   R187A; dS5b: E44A R263A) failed recruit DmPI31, indicating requirement of <br />                                                   motifs interaction DmPI31 (Figures 6E S5C). These results suggest that <br />                                                   dp27 dS5b novel interacting partners DmPI31. <br />  <br />  <br />  <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                               Page 6 <br />  <br />  <br />                               ADP-ribosylation promotes 26S proteasome assembly increasing affinity DmPI31 <br />                               assembly chaperones <br />                                                   Since ADP-ribosylation PI31 modulates 20S proteasome activity altering affinity to <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   &#945;-subunits (Figure 4), wondered post-translational modification affect <br />                                                   interaction 19S assembly chaperones p27 S5b. To examine possibility, we <br />                                                   performed anti-FLAG IP experiment using 293 cell extracts standardized FLAG- <br />                                                   dp27 HA-dRpt5 expression, followed rigorous washing addition of <br />                                                   incremental amounts vitro modified DmPI31. The effects ADP-ribosylated DmPI31 <br />                                                   stability dp27:dRpt5 dS5b:dRpt2 complexes visualized Western blot <br />                                                   (Figures 7A S6A). Countering effect &#945;4 subunit, compared its <br />                                                   unmodified version, ADP-ribosylation considerably increased ability DmPI31 to <br />                                                   recruit assembly chaperones, sequestering away Rpt base subunits a <br />                                                   dose-dependent manner (compare Figures 7A S6A Figures 7B S6B, <br />                                                   respectively). These results, presented earlier indicate ADP- <br />                                                   ribosylation directly modifies DmPI31 affinity proteasome-associated proteins. <br />  <br />                                                   Evidence role PI31 activator 26S proteasome previously based on <br />                                                   requirement protein normal proteasome activity vivo, ability this <br />                                                   protein stimulate 26S proteasome activity vitro (Bader et al., 2011). Since modification <br />                                                   ADP-ribosylation differentially affects interaction DmPI31 different proteasome <br />                                                   proteins, investigated consequences PI31-modification 26S proteasome activity <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   vitro. ADP-ribosylated DmPI31 significantly potent stimulating the <br />                                                   chymotrypsin-like activity purified 26S proteasomes vitro (Figure 7C). Furthermore, <br />                                                   modified DmPI31 incubated purified 20S 19S particles analyzed on <br />                                                   native gels, saw ADP-ribosylation increased ability DmPI31 promote de <br />                                                   novo 26S assembly vitro (Figure 7D). Finally, addition ADP-ribosylated DmPI31 <br />                                                   extracts pre-treated XAV939 reversed inhibitory effect compound 26S <br />                                                   proteasome assembly able increase 26S proteasome assembly <br />                                                   (Figure 7E). We surplus PI31 overcome effects XAV939, albeit <br />                                                   efficiently modified counterpart. This consistent observation that <br />                                                   unmodified PI31 bind sequester 19S assembly chaperones (Figure S6B). Taken <br />                                                   together, data dTNKS-dependent ADP-ribosylation DmPI31 stimulates 26S <br />                                                   proteasome activity promoting 26S assembly. <br />  <br />                               Discussion <br />                                                   It increasingly clear proteasome, thought constitutively <br />                                                   active protease complex, dynamically regulated meet changing proteolytic needs of <br />                                                   cell (Demartino Gillette, 2007; Glickman Ciechanover, 2002; Hershko and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Ciechanover, 1998). Although poly-ubiquitination substrates central select specific <br />                                                   proteins degradation, additional mechanisms exist account plasticity of <br />                                                   proteasome activity (Crosas et al., 2006; Demartino Gillette, 2007; Hanna et al., 2007; <br />                                                   Kurucz et al., 2002; Murata et al., 2009; Peth et al., 2009; Peth et al., 2013; Peth et al., 2010; <br />                                                   Princiotta et al., 2001). Here, identified TNKS novel regulator proteasome <br />                                                   activity Drosophila mammalian cells. Specifically, TNKS- <br />                                                   mediated ADP-ribosylation PI31 alters affinity protein 20S proteasome &#945;- <br />                                                   subunits 19S assembly chaperones stimulates 26S proteasome assembly. <br />                                                   Our results support model TNKS activates evolutionarily conserved <br />                                                   proteasome regulatory protein, PI31, ADP-ribosylation (Figure 7F). PI31 is <br />                                                   physiologically required optimal 26S proteasome activity vivo, inactivation the <br />                                                   corresponding gene Drosophila causes reduced protein breakdown organismal <br />                                                   lethality (Bader et al., 2011). Inhibition TNKS RNAi specific small- <br />                                                   molecule inhibitor, XAV939, blocked ADP-ribosylation PI31 impaired 26S <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                              Page 7 <br />  <br />  <br />                                                   proteasome activity similar inactivation PI31. It suggested PI31 act a <br />                                                   modulator proteasome assembly reversibly associating 20S proteasome (Besche <br />                                                   et al., 2009a; McCutchen-Maloney et al., 2000; Tai et al., 2010; Tanahashi et al., 1999; Zaiss <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   et al., 1999; Zaiss et al., 2002). In support idea, PI31 modification by <br />                                                   TNKS facilitates assembly 26S proteasome acting crucial stages (Figure <br />                                                   7F). First, TNKS-mediated ADP-ribosylation decreases affinity PI31 &#945;4 subunits <br />                                                   20S particle. This dislodges PI31 20S proteasomes prevents PI31 from <br />                                                   inhibiting 20S activity. Once free, modified PI31 competes Rpt subunits sequester <br />                                                   assembly chaperones p27 S5b away 19S regulatory particles, thereby <br />                                                   promoting capping 20S 19S particles. This consistent previous <br />                                                   observations overexpression p27, S5b Rpn14/PAAF1 proteins negatively <br />                                                   affected proteasome assembly (Kaneko et al., 2009; Lassot et al., 2007; Park et al., 2005; <br />                                                   Shim et al., 2012). By acting 20S particles assembly chaperones, PI31 appears <br />                                                   function central regulator 26S proteasome assembly (Figure 7F). Significantly, this <br />                                                   process disrupted existing small-molecule compounds: TNKS-inhibitors <br />                                                   represent novel class compounds inhibit 26S activity interfering with <br />                                                   proteasome assembly. <br />  <br />                                                   PI31 required normal proteasome activity vivo, stimulate activity <br />                                                   purified 26S proteasome vitro (Bader et al., 2011). In order explain finding, <br />                                                   invoke possibility purified 26S proteasomes used experiments contain <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   associated proteins, including 19S assembly chaperones. This consistent observations <br />                                                   showing p27 S5b association purified 26S proteasome (Besche et al., 2009a; <br />                                                   Deveraux et al., 1995; Gomes et al., 2006; Tai et al., 2010; Watanabe et al., 1998). <br />                                                   Furthermore, unmodified PI31 bind assembly chaperones, albeit lower <br />                                                   efficiency (Figure S6B). Taken together, results suggest PI31 stimulates <br />                                                   proteasome activity vitro increasing 26S particles. <br />  <br />                                                   The rate intracellular protein degradation dramatically affected various signals, <br />                                                   including metabolic state cell (Glickman Ciechanover, 2002). For example, <br />                                                   caloric restriction cause severe reduction skeletal muscles, humans loose large <br />                                                   fraction muscle mass aging. Although appears evolved a <br />                                                   protective mechanism cope food shortage, muscle atrophy highly <br />                                                   debilitating process occurs various diseases, cancer cachexia, AIDS, <br />                                                   renal failure, neuro-degenerative diseases. In cases, proteasome activity is <br />                                                   responsible protein breakdown cellular atrophy, direct connection between <br />                                                   metabolism proteasome activity established. Since NAD+ source <br />                                                   ADP-ribose group, proteasome regulation TNKS provides potential new link <br />                                                   cell metabolism regulation protein degradation (Gibson Kraus, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   2012). Because ADP-ribosylation short half-life (1&#8211;2 min), ideally suited to <br />                                                   rapidly signal transient changes cell physiology (Chambers et al., 2012; Gibson and <br />                                                   Kraus, 2012; Lindahl et al., 1995; Wang et al., 2009). We speculate TNKS-mediated <br />                                                   activation PI31 serve stimulate proteasome activity cells need to <br />                                                   dynamically boost proteolytic capacity meet changing demands, during <br />                                                   cellular remodeling, stress caloric restriction. It possible that <br />                                                   activation PI31 occurs specific subcellular compartments, example the <br />                                                   nucleus, specific neuronal processes undergoing pruning, synapses during <br />                                                   remodeling. In way, possible locally fine-tune assembly activity of <br />                                                   26S proteasomes meet cell&#8217;s changing needs controlled proteolysis. <br />  <br />                                                   The proteasome validated drug target cancer therapy bortezomib (&#8220;Velcade&#65533;?), <br />                                                   inhibits chymotrypsin-like activity proteasome, approved US for <br />                                                   treatment multiple myeloma mantle cell lymphoma (Goldberg, 2012; Kisselev et <br />  <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                          Page 8 <br />  <br />  <br />                                                   al., 2012; Raab et al., 2009). Problems associated bortezomib include notable side <br />                                                   effects, peripheral neuropathy drug resistance (Goldberg, 2012; Kisselev et al., <br />                                                   2012; Raab et al., 2009). Therefore, drugs inhibit proteasome activity separate <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   mechanism considerable clinical value. Our findings suggest TNKS- <br />                                                   inhibitors, XAV939 IWR-1, useful treatment multiple <br />                                                   myeloma, mantle cell lymphoma cancers sensitive proteasome inhibition. <br />                                                   Consistent idea, preliminary evidence XAV939 block growth <br />                                                   multiple myeloma cells (Figure S6C). Besides inhibiting proteasome activity an <br />                                                   entirely distinct mechanism, TNKS-inhibitors expected block maximal activation <br />                                                   26S function, basal activity proteasome fewer side <br />                                                   effects (Figure 7F). Interestingly, XAV939 shown effective against <br />                                                   colorectal cancer cells thought antagonize Wnt-signaling preventing the <br />                                                   degradation axin (Huang et al., 2009). However, contribution proteasome inhibition <br />                                                   paradigm determined. Proteasome regulation tankyrase-mediated <br />                                                   ADP-ribosylation provides unexpected new mechanism regulate protein degradation <br />                                                   targeted small-molecule inhibitors. <br />  <br />                               Experimental Procedures <br />                               Recombinant Protein Purification Far-Western screening cDNA library <br />                                                   For purification His-DmPI31, His-DmPI31&#916;HbYX, His-HMK-DmPI31 His- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   dTNKS&#916;PARP fusion proteins, E.coli BL21 (Invitrogen) transformed pET28- <br />                                                   His-DmPI31, pET28-His-DmPI31&#916;HbYX, pET101-His-HMK-DmPI31 pET101-His- <br />                                                   dTNKS&#916;PARP constructs. Following 2h induction 37&#176;C 0.1 mM IPTG, fusion <br />                                                   proteins purified TALON&#8482; Metal Affinity resin (BD Bioscience) according the <br />                                                   manufacturer&#8217;s instructions. For purification FLAG-dTNKS FLAG-dPARP, <br />                                                   HEK293 cell extracts expressing pcDNA3.2-FLAG-dTNKS pcDNA3.2-FLAG- <br />                                                   dPARP constructs incubated anti- FLAG&#174;M2-Affinity Gel (Sigma) 3h and <br />                                                   purified using FLAG&#174; peptide (Sigma) according manufacturer&#8217;s instructions. Far- <br />                                                   Western screening cDNA library performed previous described (Pause et al., <br />                                                   1994) using Drosophila &#955; cDNA library (Stratagene). <br />  <br />                               Cell Culture/Growth assay <br />                                                   Cationic lipid reagent (20 &#956;l Lipofectamine 2000; Invitrogen) diluted serum free <br />                                                   media (Opti-MEM; Invitrogen) transfection Human Embryonic Kidney 293 cells <br />                                                   (100mm dish). Following 5h incubation, medium replaced Dulbecco&#8217;s <br />                                                   Modified Eagle Medium(DMEM; Invitrogen) supplemented 10% Fetal Bovine Serum <br />                                                   (FBS). Transfected cells harvested PBS 48h following addition serum <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   containing media. The cells lysed repeated freeze/thaw cycles 600 &#956;l of <br />                                                   lysis buffer (20mM Hepes-KOH, pH 7.6, 200mM KCl, 0.5mM EDTA, 10% glycerol, 1% <br />                                                   Triton X-100 Protease Inhibitor Cocktail (Complete&#8482;; Roche)) contains RNAse A <br />                                                   (50 &#956;g/ml; Sigma). Cell debris pelleted centrifugation, protein concentration <br />                                                   supernatant determined using Bio-Rad assay. The siRNAs purchased from <br />                                                   Invitrogen (sequences shown Table S1) transfected 293 cells final <br />                                                   concentration 50nM/100mm dishes using Lipofectamine 2000. Effects drug treatment <br />                                                   U266 multiple myeloma cell growth performed using 0.1 &#956;M bortezomib 5 <br />                                                   &#956;M XAV939 low FBS (0.5%) RPMI media, 96 plates seeded ~8000 <br />                                                   cells/well. Samples assayed growth/viability using PrestoBlue&#174; Cell Viability <br />                                                   Reagent (Invitrogen) Spectramax M2 reader (Molecular Devices) manufacturer&#8217;s <br />                                                   instructions. <br />  <br />  <br />  <br />  <br />                                                          Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                         Page 9 <br />  <br />  <br />                               Co-Immunoprecipitation <br />                                                   For co-immunoprecipitation, 293 cell extract (200 &#956;l; 6&#8211;10 &#956;g/ &#956;l) brought 1ml <br />                                                   lysis buffer pre-cleared 1h 4&#176;C 25 &#956;l Protein A Sepharose (GE <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Healthcare). The supernatant immunoprecipitated 1h 4&#176;C 25 &#956;l anti- <br />                                                   FLAG&#174;M2-Affinity Gel (Sigma). The resin washed twice lysis buffer once <br />                                                   lysis buffer containing 300mM KCl. Immunoprecipitates eluted 3X red sample <br />                                                   buffer (NEB). For anti-HA anti-DmPI31 immunoprecipitations, 25 &#956;l Protein A <br />                                                   Sepharose pre-incubated 2h anti-HA (3 &#956;l) anti-DmPI31 (5 &#956;l). The <br />                                                   resins washed times lysis buffer prior immunoprecipitation as <br />                                                   described above. Embryo extracts used concentration 5 &#956;g/ &#956;l. <br />  <br />                               Proteasome activity Assay <br />                                                   50 &#956;g 0&#8211;2h WT (yw) embryo 3 &#956;g 293 cell extracts PIPES buffer (50mM PIPES, <br />                                                   1mMMgCl2, 50mM NaCl, 2mM EGTA 2mM ATP) programmed 1% DMSO <br />                                                   (Sigma), 5 &#956;M MG132 (Calbiochem), 2 &#956;M XAV939 (Sigma) 2 &#956;M IWR-1 (Sigma), <br />                                                   respectively, incubated 20 min room temperature. Samples assayed for <br />                                                   proteasome activity using Proteasome-Glo&#8482; Chymotrypsin-like Cell-Based assay <br />                                                   (Promega) Spectramax M2 reader (Molecular Devices). To assess effect ADP- <br />                                                   ribosylation 20S 26S proteasome activities purified bovine 20S 26S <br />                                                   proteasomes (0.1 &#956;g; UBPBio) PIPES buffer + 2mM ATP programmed 2 &#956;g <br />                                                   His-DmPI31WT, His-DmPI31&#916;HbYX His-DmPI31ADPR, incubated 20 min at <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   room temperature. Samples assayed proteasome activity described above. <br />  <br />                               Gel Filtration assay <br />                                                   2mg 0&#8211;2h WT embryo extracts prepared using PIPES buffer + 2mM ATP were <br />                                                   centrifuged twice 14 000 rpm 20 min 4&#176;C prior treated 50 &#956;g His- <br />                                                   DmPI31, 50 &#956;g His-DmPI31&#916;HbYX, 50 &#956;g His-DmPI31ADP-ribosylation, 1% DMSO, 5 &#956;M <br />                                                   MG132, 2&#956;M XAV939 2 &#956;M Olaparib (LC laboratories) 30 min. Gel filtration <br />                                                   assay subsequently performed using Superose 6 10/300GL FPLC column (AKTA; GE <br />                                                   Healthcare). 500 &#956;l fractions collected using 0.250 ml/min flow rate. Purified bovine <br />                                                   19S, 20S 26S proteasomes (UBPBio), thyroglobulin, BSA used standards. <br />  <br />                               In vitro ADP-ribosylation Assay Purification His-DmPI31ADPR <br />                                                   Recombinant His-DmPI31 (1 &#956;g), FLAG-dTNKS (0.1 &#956;g) His-dTNKS&#916;PARP (0.1 &#956;g), <br />                                                   biotin-NAD+ (3.5 &#956;M; Trevigen) incubated 5h 37&#176;C subjected <br />                                                   SDS-PAGE followed Western Blotting using Streptavidin-HRP (Thermo-Scientific; <br />                                                   1:10000). Effect XAV939 dTNKS dPARP assessed incubating FLAG- <br />                                                   dTNKS FLAG-dPARP/Biotin-NAD+ mixture 0.1% DMSO 0.1 &#956;M <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   XAV939. For purification His-DmPI31ADPR protein, vitro ADP-ribosylation of <br />                                                   recombinant His-DmPI31 protein performed above. This followed serial <br />                                                   purifications using TALON Metal Affinity resin (ClonTech) SoftLink&#8482; Soft Release <br />                                                   Avidin resin (Promega) manufactures&#8217; instructions. <br />  <br />                               Native Gel analysis <br />                                                   To analyze proteasome assembly status, 200 &#956;g embryo extracts exposed different <br />                                                   experimental conditions + 2mM ATP resolved using 5% Tris-HCl acrylamide gels <br />                                                   (Bio-rad) non-denaturing conditions transferred 0.22 &#956;m PVDF <br />                                                   membrane. Western blot analysis using specific antibodies performed described <br />                                                   above. Concentrations various reagents were: 1% DMSO, 5 &#956;M MG132, 2 &#956;M XAV939, <br />                                                   purified bovine 19S 20S (1 &#956;g), 5&#956;g His-DmPI31WT, His-DmPI31&#916;HbYX and <br />                                                   His-DmPI31ADPR proteins. <br />  <br />  <br />                                                          Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                                              Page 10 <br />  <br />  <br />                               Fly Strains <br />                                                   UAS-DTS5 UAS-DTS7 lines obtained J. Belote, dTNKS (21930, 21932 and <br />                                                   106238), dp27 (28527, 47762 47763), dS5b (104492) dRpn14 (32697 32698) <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   RNAi lines obtained Vienna Drosophila RNAi Center (VDRC) and <br />                                                   Bloomington Drosophila Stock Center. <br />  <br />                               Supplementary Material <br />                                                   Refer Web version PubMed Central supplementary material. <br />  <br />  <br />                               Acknowledgments <br />                                                   In alphabetical order, thank J. Belote providing fly strains; G. DeMartino, A. Goldberg S. Larisch for <br />                                                   critical comments manuscript; S. Benjamin-Hong, O. Cho, I.B. Cho-Park, Y.A. Cho-Park, D. Ferres-Marco, <br />                                                   N. Gandagar, T. Hsiao, A. Kelkar, L.I. Park, C. Pham, J. Rodriguez, I. Sachrai, C. Sandu members lab <br />                                                   valuable discussions; J. Gee-Esposito, T. Gorenc, O. Matthew A. Persaud logistical support. H.S. an <br />                                                   Investigator Howard Hughes Medical Institute. This work supported NIH grant RO1GM60124 to <br />                                                   H.S. <br />  <br />  <br />                               References <br />                                                   Bader M, Benjamin S, Wapinski OL, Smith DM, Goldberg AL, Steller H. A conserved F box <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                     regulatory complex controls proteasome activity Drosophila. Cell. 2011; 145:371&#8211;382. [PubMed: <br />                                                     21529711] <br />                                                   Barrault MB, Richet N, Godard C, Murciano B, Le Tallec B, Rousseau E, Legrand P, Charbonnier JB, <br />                                                     Le Du MH, Guerois R, et al. Dual functions Hsm3 protein chaperoning scaffolding <br />                                                     regulatory particle subunits proteasome assembly. Proc Natl Acad Sci U S A. 2012; <br />                                                     109:E1001&#8211;1010. [PubMed: 22460800] <br />                                                   Baumeister W, Walz J, Zuhl F, Seemuller E. The proteasome: paradigm self-compartmentalizing <br />                                                     protease. Cell. 1998; 92:367&#8211;380. [PubMed: 9476896] <br />                                                   Belote JM, Fortier E. Targeted expression dominant negative proteasome mutants Drosophila <br />                                                     <span id='am-38' about='obo:NCBITaxon_80614' typeof='owl:Thing obo:NCBITaxon_80611 obo:NCBITaxon_1 obo:NCBITaxon_5302 obo:NCBITaxon_131567 obo:NCBITaxon_4751 obo:NCBITaxon_33154 obo:NCBITaxon_452333 obo:NCBITaxon_5204 obo:NCBITaxon_451864 obo:NCBITaxon_68889 obo:NCBITaxon_155619 obo:NCBITaxon_2759'><span id='am-39'  ></span><span id='am-40' property="rdfs:label" content="Melanogaster" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>melanogaster</span>. Genesis. 2002; 34:80&#8211;82. [PubMed: 12324954] <br />                                                   Besche HC, Haas W, Gygi SP, Goldberg AL. Isolation mammalian 26S proteasomes p97/VCP <br />                                                     complexes using ubiquitin-like domain HHR23B reveals novel proteasome-associated <br />                                                     proteins. Biochemistry. 2009a; 48:2538&#8211;2549. [PubMed: 19182904] <br />                                                   Besche HC, Peth A, Goldberg AL. Getting base proteasome assembly. Cell. 2009b; 138:25&#8211; <br />                                                     28. [PubMed: 19596233] <br />                                                   Chambers JE, <span id='am-33' about='obo:NCBITaxon_692029' typeof='owl:Thing obo:NCBITaxon_37567 obo:NCBITaxon_33340 obo:NCBITaxon_37568 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_81687 obo:NCBITaxon_85604 obo:NCBITaxon_104430 obo:NCBITaxon_33154 obo:NCBITaxon_581385 obo:NCBITaxon_33317 obo:NCBITaxon_41191 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_41196 obo:NCBITaxon_197563 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7139 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-34' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-36'  ></span><span id='am-37' property="rdfs:label" content="Petrova" datatype="xsd:string"></span>Petrova</span> K, Tomba G, Vendruscolo M, Ron D. ADP ribosylation adapts ER <br />                                                     chaperone response short-term fluctuations unfolded protein load. J Cell Biol. 2012; 198:371&#8211; <br />                                                     385. [PubMed: 22869598] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan CW, Wei S, Hao W, Kilgore J, Williams NS, et al. <br />                                                     Small molecule-mediated disruption Wnt-dependent signaling tissue regeneration cancer. <br />                                                     Nat Chem Biol. 2009; 5:100&#8211;107. [PubMed: 19125156] <br />                                                   Chiang YJ, Hsiao SJ, Yver D, Cushman SW, Tessarollo L, Smith S, Hodes RJ. Tankyrase 1 and <br />                                                     tankyrase 2 essential redundant mouse embryonic development. PLoS One. 2008; <br />                                                     3:e2639. [PubMed: 18612384] <br />                                                   Chiang YJ, Nguyen ML, Gurunathan S, Kaminker P, Tessarollo L, Campisi J, Hodes RJ. Generation <br />                                                       characterization telomere length maintenance tankyrase 2-deficient mice. Mol Cell Biol. <br />                                                       2006; 26:2037&#8211;2043. [PubMed: 16507984] <br />                                                   Chu-Ping M, Slaughter CA, DeMartino GN. Purification characterization protein inhibitor of <br />                                                       20S proteasome (macropain). Biochim Biophys Acta. 1992; 1119:303&#8211;311. [PubMed: <br />                                                       1312359] <br />                                                   Crosas B, Hanna J, Kirkpatrick DS, Zhang DP, Tone Y, Hathaway NA, Buecker C, Leggett DS, <br />                                                       Schmidt M, King RW, et al. Ubiquitin chains remodeled proteasome opposing <br />                                                       ubiquitin ligase deubiquitinating activities. Cell. 2006; 127:1401&#8211;1413. [PubMed: 17190603] <br />  <br />  <br />                                                            Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                                   Page 11 <br />  <br />  <br />                                                   D&#8217;Amours D, Desnoyers S, D&#8217;Silva I, Poirier GG. Poly(ADP-ribosyl)ation reactions regulation <br />                                                       nuclear functions. Biochem J. 1999; 342(Pt 2):249&#8211;268. [PubMed: 10455009] <br />                                                   Demartino GN, Gillette TG. Proteasomes: machines reasons. Cell. 2007; 129:659&#8211;662. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       [PubMed: 17512401] <br />                                                   Deveraux Q, Jensen C, Rechsteiner M. Molecular cloning expression 26 S protease subunit <br />                                                       enriched dileucine repeats. J Biol Chem. 1995; 270:23726&#8211;23729. [PubMed: 7559544] <br />                                                   Finley D. Recognition processing ubiquitin-protein conjugates proteasome. Annu Rev <br />                                                       Biochem. 2009; 78:477&#8211;513. [PubMed: 19489727] <br />                                                   Funakoshi M, Tomko RJ Jr, Kobayashi H, Hochstrasser M. Multiple assembly chaperones govern <br />                                                       biogenesis proteasome regulatory particle base. Cell. 2009; 137:887&#8211;899. [PubMed: <br />                                                       19446322] <br />                                                   Gagne JP, Hendzel MJ, Droit A, Poirier GG. The expanding role poly(ADP-ribose) metabolism: <br />                                                       current challenges new perspectives. Curr Opin Cell Biol. 2006; 18:145&#8211;151. [PubMed: <br />                                                       16516457] <br />                                                   Gibson BA, Kraus WL. New insights molecular cellular functions poly(ADP-ribose) <br />                                                       PARPs. Nat Rev Mol Cell Biol. 2012; 13:411&#8211;424. [PubMed: 22713970] <br />                                                   Gillette TG, Kumar B, Thompson D, Slaughter CA, DeMartino GN. Differential roles COOH <br />                                                       termini AAA subunits PA700 (19 S regulator) asymmetric assembly activation the <br />                                                       26 S proteasome. J Biol Chem. 2008; 283:31813&#8211;31822. [PubMed: 18796432] <br />                                                   Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction sake <br />                                                       construction. Physiol Rev. 2002; 82:373&#8211;428. [PubMed: 11917093] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Goldberg AL. On prions, proteasomes, mad cows. N Engl J Med. 2007; 357:1150&#8211;1152. <br />                                                       [PubMed: 17855677] <br />                                                   Goldberg AL. Development proteasome inhibitors research tools cancer drugs. J Cell Biol. <br />                                                       2012; 199:583&#8211;588. [PubMed: 23148232] <br />                                                   Gomes AV, Zong C, Edmondson RD, Li X, Stefani E, Zhang J, Jones RC, Thyparambil S, Wang GW, <br />                                                       Qiao X, et al. Mapping murine cardiac 26S proteasome complexes. Circ Res. 2006; 99:362&#8211; <br />                                                       371. [PubMed: 16857966] <br />                                                   Guettler S, LaRose J, Petsalaki E, Gish G, Scotter A, Pawson T, Rottapel R, Sicheri F. Structural basis <br />                                                       sequence rules substrate recognition Tankyrase explain basis cherubism disease. <br />                                                       Cell. 2011; 147:1340&#8211;1354. [PubMed: 22153077] <br />                                                   Hanna J, Meides A, Zhang DP, Finley D. A ubiquitin stress response induces altered proteasome <br />                                                       composition. Cell. 2007; 129:747&#8211;759. [PubMed: 17512408] <br />                                                   Hershko A. The ubiquitin protein degradation roles control cell <br />                                                       division cycle. Cell Death Differ. 2005; 12:1191&#8211;1197. [PubMed: 16094395] <br />                                                   Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998; 67:425&#8211;479. [PubMed: <br />                                                       9759494] <br />                                                   Hsiao SJ, Poitras MF, Cook BD, Liu Y, Smith S. Tankyrase 2 poly(ADP-ribose) polymerase domain- <br />                                                       deleted mice exhibit growth defects normal telomere length capping. Mol Cell Biol. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       2006; 26:2044&#8211;2054. [PubMed: 16507985] <br />                                                   Hsiao SJ, Smith S. Tankyrase function telomeres, spindle poles, beyond. Biochimie. 2008; <br />                                                       90:83&#8211;92. [PubMed: 17825467] <br />                                                   Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang <br />                                                       Y, Wiessner S, et al. Tankyrase inhibition stabilizes axin antagonizes Wnt signalling. Nature. <br />                                                       2009; 461:614&#8211;620. [PubMed: 19759537] <br />                                                   Kaneko T, Hamazaki J, Iemura S, Sasaki K, Furuyama K, Natsume T, Tanaka K, Murata S. Assembly <br />                                                       pathway Mammalian proteasome base subcomplex mediated multiple specific <br />                                                       chaperones. Cell. 2009; 137:914&#8211;925. [PubMed: 19490896] <br />                                                   Kisselev AF, van der Linden WA, Overkleeft HS. Proteasome inhibitors: expanding army attacking <br />                                                       unique target. Chem Biol. 2012; 19:99&#8211;115. [PubMed: 22284358] <br />                                                   Kurucz E, Ando I, Sumegi M, Holzl H, Kapelari B, Baumeister W, Udvardy A. Assembly the <br />                                                       Drosophila 26 S proteasome accompanied extensive subunit rearrangements. Biochem J. <br />                                                       2002; 365:527&#8211;536. [PubMed: 11945175] <br />  <br />  <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                                  Page 12 <br />  <br />  <br />                                                   Lander GC, Estrin E, Matyskiela ME, Bashore C, Nogales E, Martin A. Complete subunit architecture <br />                                                       proteasome regulatory particle. Nature. 2012; 482:186&#8211;191. [PubMed: 22237024] <br />                                                   Lasker K, Forster F, Bohn S, Walzthoeni T, <span id='am-28' about='obo:NCBITaxon_117093' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_117077 obo:NCBITaxon_33154 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_50704 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_6656 obo:NCBITaxon_50674 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_50557 obo:NCBITaxon_50671'><span id='am-29'  ></span><span id='am-30' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-31' property="rdfs:label" content="Villa" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Villa</span> E, Unverdorben P, Beck F, Aebersold R, Sali A, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       Baumeister W. Molecular architecture 26S proteasome holocomplex determined an <br />                                                       integrative approach. Proc Natl Acad Sci U S A. 2012; 109:1380&#8211;1387. [PubMed: 22307589] <br />                                                   Lassot I, Latreille D, Rousset E, Sourisseau M, Linares LK, Chable-Bessia C, Coux O, Benkirane M, <br />                                                       Kiernan RE. The proteasome regulates HIV-1 transcription proteolytic nonproteolytic <br />                                                       mechanisms. Mol Cell. 2007; 25:369&#8211;383. [PubMed: 17289585] <br />                                                   Le Tallec B, Barrault MB, Guerois R, Carre T, Peyroche A. Hsm3/S5b participates assembly <br />                                                       pathway 19S regulatory particle proteasome. Mol Cell. 2009; 33:389&#8211;399. [PubMed: <br />                                                       19217412] <br />                                                   Lee SY, De la Mota-Peynado A, Roelofs J. Loss Rpt5 protein interactions core particle and <br />                                                       Nas2 protein causes formation faulty proteasomes inhibited Ecm29 protein. J <br />                                                       Biol Chem. 2011; 286:36641&#8211;36651. [PubMed: 21878651] <br />                                                   Levaot N, Voytyuk O, Dimitriou I, Sircoulomb F, Chandrakumar A, Deckert M, Krzyzanowski PM, <br />                                                       Scotter A, Gu S, Janmohamed S, et al. Loss Tankyrase-mediated destruction 3BP2 the <br />                                                       underlying pathogenic mechanism cherubism. Cell. 2011; 147:1324&#8211;1339. [PubMed: <br />                                                       22153076] <br />                                                   Lindahl T, Satoh MS, Poirier GG, Klungland A. Post-translational modification poly(ADP-ribose) <br />                                                       polymerase induced DNA strand breaks. Trends Biochem Sci. 1995; 20:405&#8211;411. [PubMed: <br />                                                       8533153] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   McCutchen-Maloney SL, Matsuda K, Shimbara N, Binns DD, Tanaka K, Slaughter CA, DeMartino <br />                                                       GN. cDNA cloning, expression, functional characterization PI31, proline-rich inhibitor of <br />                                                       proteasome. J Biol Chem. 2000; 275:18557&#8211;18565. [PubMed: 10764772] <br />                                                   Morrone S, Cheng Z, Moon RT, Cong F, Xu W. Crystal structure Tankyrase-Axin complex its <br />                                                       implications Axin turnover Tankyrase substrate recruitment. Proc Natl Acad Sci U S A. <br />                                                       2012; 109:1500&#8211;1505. [PubMed: 22307604] <br />                                                   Murata S, Yashiroda H, Tanaka K. Molecular mechanisms proteasome assembly. Nat Rev Mol Cell <br />                                                       Biol. 2009; 10:104&#8211;115. [PubMed: 19165213] <br />                                                   Narwal M, Venkannagari H, Lehtio L. Structural basis selective inhibition human tankyrases. J <br />                                                       Med Chem. 2012; 55:1360&#8211;1367. [PubMed: 22233320] <br />                                                   Nickell S, Mihalache O, Beck F, Hegerl R, Korinek A, Baumeister W. Structural analysis 26S <br />                                                       proteasome cryoelectron tomography. Biochem Biophys Res Commun. 2007; 353:115&#8211;120. <br />                                                       [PubMed: 17173858] <br />                                                   Park S, Roelofs J, Kim W, Robert J, Schmidt M, Gygi SP, Finley D. Hexameric assembly the <br />                                                       proteasomal ATPases templated C termini. Nature. 2009; 459:866&#8211;870. [PubMed: <br />                                                       19412160] <br />                                                   Park Y, Hwang YP, Lee JS, Seo SH, Yoon SK, Yoon JB. Proteasomal ATPase-associated factor 1 <br />                                                       negatively regulates proteasome activity interacting proteasomal ATPases. Mol Cell Biol. <br />                                                       2005; 25:3842&#8211;3853. [PubMed: 15831487] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Pause A, Belsham GJ, Gingras AC, Donze O, Lin TA, Lawrence JC Jr, Sonenberg N. Insulin- <br />                                                       dependent stimulation protein synthesis phosphorylation regulator 5&#8242;-cap function. <br />                                                       Nature. 1994; 371:762&#8211;767. [PubMed: 7935836] <br />                                                   Peth A, Besche HC, Goldberg AL. Ubiquitinated proteins activate proteasome binding to <br />                                                       Usp14/Ubp6, causes 20S gate opening. Mol Cell. 2009; 36:794&#8211;804. [PubMed: 20005843] <br />                                                   Peth A, Kukushkin N, Bosse M, Goldberg AL. Ubiquitinated proteins activate proteasomal <br />                                                       ATPases binding Usp14 Uch37. J Biol Chem. 2013 <br />                                                   Peth A, Uchiki T, Goldberg AL. ATP-dependent steps binding ubiquitin conjugates the <br />                                                       26S proteasome commit degradation. Mol Cell. 2010; 40:671&#8211;681. [PubMed: 21095592] <br />                                                   Princiotta MF, Schubert U, Chen W, Bennink JR, Myung J, Crews CM, Yewdell JW. Cells adapted to <br />                                                       proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone <br />                                                       require enzymatically active proteasomes continued survival. Proc Natl Acad Sci U S A. 2001; <br />                                                       98:513&#8211;518. [PubMed: 11149939] <br />  <br />  <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                                Page 13 <br />  <br />  <br />                                                   Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC. Multiple myeloma. Lancet. 2009; <br />                                                       374:324&#8211;339. [PubMed: 19541364] <br />                                                   Rabl J, Smith DM, Yu Y, Chang SC, Goldberg AL, Cheng Y. Mechanism gate opening 20S <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       proteasome proteasomal ATPases. Mol Cell. 2008; 30:360&#8211;368. [PubMed: 18471981] <br />                                                   Roelofs J, Park S, Haas W, Tian G, McAllister FE, Huo Y, Lee BH, Zhang F, Shi Y, Gygi SP, Finley <br />                                                       D. Chaperone-mediated pathway proteasome regulatory particle assembly. Nature. 2009; <br />                                                       459:861&#8211;865. [PubMed: 19412159] <br />                                                   Saeki Y, Toh EA, Kudo T, Kawamura H, Tanaka K. Multiple proteasome-interacting proteins assist <br />                                                       assembly yeast 19S regulatory particle. Cell. 2009; 137:900&#8211;913. [PubMed: 19446323] <br />                                                   Shim SM, Lee WJ, Kim Y, Chang JW, Song S, Jung YK. Role S5b/PSMD5 proteasome <br />                                                       inhibition caused TNF-alpha/NFkappaB higher eukaryotes. Cell Rep. 2012; 2:603&#8211;615. <br />                                                       [PubMed: 22921402] <br />                                                   Smith DM, Chang SC, Park S, Finley D, Cheng Y, Goldberg AL. Docking proteasomal <br />                                                       ATPases&#8217; carboxyl termini 20S proteasome&#8217;s alpha ring opens gate substrate entry. <br />                                                       Mol Cell. 2007; 27:731&#8211;744. [PubMed: 17803938] <br />                                                   Smith S, Giriat I, Schmitt A, Lange T. Tankyrase, poly(ADP-ribose) polymerase human <br />                                                       telomeres. Science. 1998; 282:1484&#8211;1487. [PubMed: 9822378] <br />                                                   Tai HC, Besche H, Goldberg AL, Schuman EM. Characterization Brain 26S Proteasome its <br />                                                       Interacting Proteins. Front Mol Neurosci. 2010:3. [PubMed: 20407580] <br />                                                   Takagi K, Kim S, Yukii H, Ueno M, Morishita R, Endo Y, Kato K, Tanaka K, Saeki Y, Mizushima T. <br />                                                       Structural basis specific recognition Rpt1p, ATPase subunit 26 S proteasome, by <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       proteasome-dedicated chaperone Hsm3p. J Biol Chem. 2012; 287:12172&#8211;12182. [PubMed: <br />                                                       22334676] <br />                                                   Tanahashi N, Kawahara H, Murakami Y, Tanaka K. The proteasome-dependent proteolytic system. <br />                                                       Mol Biol Rep. 1999; 26:3&#8211;9. [PubMed: 10363639] <br />                                                   Tanaka K, Mizushima T, Saeki Y. The proteasome: molecular machinery pathophysiological <br />                                                       roles. Biol Chem. 2012; 393:217&#8211;234. [PubMed: 23029643] <br />                                                   Tomko RJ Jr, Hochstrasser M. Order proteasomal ATPases eukaryotic proteasome <br />                                                       assembly. Cell Biochem Biophys. 2011; 60:13&#8211;20. [PubMed: 21461838] <br />                                                   Varshavsky A. The ubiquitin system, immense realm. Annu Rev Biochem. 2012; 81:167&#8211;176. <br />                                                       [PubMed: 22663079] <br />                                                   Wang Y, Dawson VL, Dawson TM. Poly(ADP-ribose) signals mitochondrial AIF: key event in <br />                                                       parthanatos. Exp Neurol. 2009; 218:193&#8211;202. [PubMed: 19332058] <br />                                                   Watanabe TK, Saito A, Suzuki M, Fujiwara T, Takahashi E, Slaughter CA, DeMartino GN, Hendil <br />                                                       KB, Chung CH, Tanahashi N, Tanaka K. cDNA cloning characterization human <br />                                                       proteasomal modulator subunit, p27 (PSMD9). Genomics. 1998; 50:241&#8211;250. [PubMed: 9653651] <br />                                                   Yeh TY, Beiswenger KK, Li P, Bolin KE, Lee RM, Tsao TS, Murphy AN, Hevener AL, Chi NW. <br />                                                       Hypermetabolism, hyperphagia, reduced adiposity tankyrase-deficient mice. Diabetes. <br />                                                       2009; 58:2476&#8211;2485. [PubMed: 19651815] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Zaiss DM, Standera S, Holzhutter H, Kloetzel P, Sijts AJ. The proteasome inhibitor PI31 competes <br />                                                       PA28 binding 20S proteasomes. FEBS Lett. 1999; 457:333&#8211;338. [PubMed: 10471803] <br />                                                   Zaiss DM, Standera S, Kloetzel PM, Sijts AJ. PI31 modulator proteasome formation and <br />                                                       antigen processing. Proc Natl Acad Sci U S A. 2002; 99:14344&#8211;14349. [PubMed: 12374861] <br />  <br />  <br />  <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                  Page 14 <br />  <br />  <br />                                                                                           Highlights <br />                                                   &#8226;    TNKS modifies proteasome regulator PI31 ADP -ribosylation <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   &#8226;    ADP-ribosylation alters PI31 affinity proteasome proteins <br />                                                   &#8226;    TNKS regulates 26S proteasome activity controlling assembly <br />                                                   &#8226;    TNKS-inhibitors represent new class agents block 26S assembly <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                     Page 15 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Figure 1. dTNKS, novel interacting partner DmPI31 <br />                                                   (A) dTNKS antiserum detects purified dTNKS. Purified FLAG-tagged dTNKS detected <br />                                                   Western blot dTNKS antiserum (lane 3), pre-immune serum (lane <br />                                                   2). (B) 0&#8211;2h yw (WT) embryo extract used anti-DmPI31 immunoprecipitation (IP) <br />                                                   demonstrate DmPI31 interacts dTNKS vivo. (C) A DmPI31:dTNKS complex <br />                                                   form mammalian 293 cells. Anti-FLAG IP experiment performed using extracts <br />                                                   293 cells expressing FLAG-tagged dTNKS HA-tagged deIF4A (negative <br />                                                   control) DmPI31. (D) Schematic representation WT mutant dTNKS their <br />                                                   respective domains. Numbers denote amino acid positions. (E) dTNKS recruits DmPI31 <br />                                                   ANK domain demonstrated Co-IP experiment using 293 cell extracts <br />                                                   expressing HA-tagged DmPI31 FLAG-tagged dTNKSWT, dTNKS &#916;SAM-PARP and <br />                                                   dTNKS &#916;ANK. (F) Alignments TNKS-binding motif human 3BP2 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   (Guettler et al., 2011; Levaot et al., 2011) DmPI31 reveal presence putative <br />                                                   motif DmPI31. Numbers indicate position residues DmPI31. (G) dTNKS <br />                                                   interacts multiple DmPI31 surfaces: putative DmPI31 TNKS-binding motif <br />                                                   (RG49/54AA) conserved C-terminal residues (D211 P243) including HbYX- <br />                                                   domain. See Figure S1. <br />  <br />  <br />  <br />  <br />                                                          Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                             Page 16 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Figure 2. dTNKS post-translationally modifies PI31 ADP-ribosylation regulate 26S <br />                                                   proteasome activity <br />                                                   (A) DmPI31 poly ADP-ribosylated vivo. Endogenous DmPI31 ADP-ribosylation was <br />                                                   detected using 0&#8211;2h WT embryo extracts immuno-precipitated anti-DmPI31. Eluted <br />                                                   proteins analyzed Western blotting using anti-poly ADP-ribose (PAR) antibody. <br />                                                   (B) dTNKS directly ADP-ribosylates DmPI31 vitro dependent PARP <br />                                                   domain. Samples containing Biotin-NAD+, His-DmPI31, FLAG-dTNKSWT His- <br />                                                   dTNKS &#916;PARP analyzed ADP-ribosylation Western analysis. Input proteins <br />                                                   analyzed Western blotting (right panel). (C D) Tools used investigate <br />                                                   role TNKS 26S proteasome regulation. (C) XAV939 inhibits Drosophila TNKS <br />                                                   (dTNKS) vitro, indicating activity drug conserved <span id='am-22' about='obo:NCBITaxon_species' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-23' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-24' property="rdfs:label" content="species" datatype="xsd:string"></span>species</span>. (D) <br />                                                   siRNAs targeting hTNKS1 hTNKS2 efficiently knocked-down expressions 293 cells. <br />                                                   &#945;-tubulin used loading control. (E F) TNKS inhibition XAV939 reduces <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   proteasome activity Drosophila embryo (E) 293 cell (F) extracts. (G) Reduced <br />                                                   hTNKS1 hTNKS2 levels inhibit 26S proteasome activity. (E&#8211;G) Data presented as <br />                                                   mean &#177; standard deviation independent experiments. Values obtained DMSO <br />                                                   (E&#8211;F) control siRNA (G) set 100%. (E) *, p=0.01; (F) *, p=0.05; (G) *, p=0.04 <br />                                                   **, p=0.006. Statistical analysis performed two-tailed, paired, t-test. See also <br />                                                   Figure S2. <br />  <br />  <br />  <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                       Page 17 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Figure 3. dTNKS dp27 RNAi enhances compromised proteasome activity <br />                                                   To test dTNKS dp27 role modulating proteasome activity vivo, expressed <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   RNAi dTNKS (21930, 21932 106238; C&#8211;E) dp27 (28527, 47762 and <br />                                                   47763; F&#8211;L) background dominant-negative temperature sensitive mutants (UAS- <br />                                                   DTS5 UAS-DTS7) 29&#176;C. As expected, down-regulation factors resulted a <br />                                                   significant enhancement mutant rough reduced eye phenotype (compare panels B to <br />                                                   C&#8211;L) dp27 RNAi lines, caused male lethality. These observations indicative <br />                                                   reduced proteasome activities tissues. GMR-Gal4 expression caused no <br />                                                   discernable eye defects (panel A). Orientation eyes anterior left dorsal up. <br />  <br />  <br />  <br />  <br />                                                          Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                       Page 18 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Figure 4. ADP-ribosylation relieves 20S inhibition PI31 <br />                                                   (A) DmPI31 interacts 20S proteasomes select &#945;-subunits: &#945;1, &#945;3, &#945;4 &#945;6. (B) <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   ADP-ribosylation significantly decreases affinity DmPI31 &#945;4. FLAG- &#945;4 <br />                                                   expressing 293 cell extract incubated modified DmPI31 (His-DmPI31ADPR) test <br />                                                   effect &#945;4:DmPI31 complex. Chemoluminescence quantitated using <br />                                                   ImageQuant LAS-4000 (GE Healthcare). &#945;4-binding reported relative of <br />                                                   immunoprecipitated His-DmPI31 compared level input His-DmPI31. (C) <br />                                                   Modification DmPI31 relieves inhibitory effect 20S proteasomes. Purified bovine <br />                                                   20S proteasomes (0.1 &#956;g) incubated His-DmPI31 His-DmPI31ADPR proteins <br />                                                   (2 &#956;g each), chymotrypsin-like proteasome activity measured. Data presented as <br />                                                   mean &#177; standard deviation independent experiments. The value obtained 20S <br />                                                   proteasome set 100%. *, p=0.04, **, p=0.6 ***, p=0.045. Statistical analysis was <br />                                                   performed two-tailed, paired, t-test. <br />  <br />  <br />  <br />  <br />                                                           Cell. Author manuscript; available PMC 2013 October 25. <br />                             Cho-Park Steller                                                                                         Page 19 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Figure 5. TNKS PI31 regulate proteasome assembly <br />                                                   (A) Inhibition dTNKS XAV939 led drastic shift proteasome profile to <br />                                                   &#8220;lighter&#65533;? fractions, indicative reduced 26S particles. To assess effect of <br />                                                   TNKS activity 26S assembly, embryo extracts treated XAV939 subjected to <br />                                                   Superose 6 gel filtration chromatography. (B) TNKS inhibition severely affects 26S <br />                                                   proteasome assembly. The effect XAV939 proteasome assembly embryo extracts <br />                                                   assessed native gel analysis. (C) Similar XAV939, surplus DmPI31 dramatically <br />                                                   affected proteasome assembly. Furthermore, caused i <br /> </body></html>